TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
QNCX

Quince Therapeutics, Inc.

Healthcare · Biotechnology

30.00$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow QNCX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-91.20 -108.53 -349.70 -348.35 -423.52 -262.94 -98.25 -147.49 -165.38
0.42 0.47 1.98 2.28 2.32 1.22 1.73 0.86 0.57
0.35 1.44 21.61 99.19 200.90 99.22 28.04 21.94 20.38
– 3.95 16.93 106.06 208.15 99.22 – – –
4.27 -3.62 20.01 70.11 -28.68 -58.69 10.62 -2.24 51.27
0.71 1.97 0.58 0.36 1.21 0.79 0.86 1.19 1.41
-0.71 -433.89 -186.50 -359.41 396.73 107.49 -30.93 101.28 92.73
– – – – – 98.54 342.30 – –
– 2.32 -5.87 -0.23 -0.33 -0.29 -0.03 0.00 –
71.92 704.63 813.01 814.88 45.82 4.22 0.77 -22.07 71.50
-19.99 162.21 276.82 107.12 19.40 -150.13 -127.97 -67.22 -1.61
-91.91 -110.50 -350.27 -348.71 -424.73 -263.73 -99.11 -148.68 -166.78

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?